Shilpa Medicare Limited SHILPAMED

ताज़ा फ़ाइलिंग

• Routine29 26 Sept, 14:23 · BSE
  The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 26, 2026 for Ramakant Innani & Others
• Routine15 25 Sept, 11:47 · NSE
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
• Credit rating73 23 Sept, 15:08 · NSE
  Assignment of ESG Rating by CRISIL ESG Ratings.
• Routine15 22 Sept, 15:45 · BSE
  Investors/Analysts meet
• Routine15 22 Sept, 15:11 · NSE
  Schedule of meet
• Approval73 18 Sept, 18:59 · NSE
  USFDA Inspection of Shilpa Medicare Limited, Unit VII, Analytical Services Division, Hyderabad.
• Routine15 12 Sept, 16:19 · BSE
  Submission of Scrutinizers Report on 39th AGM Resolutions along with Voting Results
• Routine15 12 Sept, 16:04 · NSE
  Voting results of Annual General Meeting held on September 11, 2026
• Approval70 11 Sept, 13:26 · NSE
  A press release dated September 11, 2026, titled "Shilpa Medicare's Novel Complex Injectable OERIS (Ondansetron Extended-Release Injection, 100 mg/mL) receives final approval from Subject Expert Committee (SEC) for grant of marketing authorization.".
• Routine15 11 Sept, 13:04 · NSE
  Proceedings of Annual General Meeting held on September 11, 2026

प्रकाशन के 15 मिनट बाद दिखाई गई। Pro में रियल-टाइम।